Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director
-
Stock Symbol
-
AVTE on Nasdaq
David S. Grayzel - trading volume in the past year for Aerovate Therapeutics, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
1.78M |
$50.2M |
$28.15 |
Apr 9, 2024 |
By Atlas Venture Fund XII, L.P. |
|
|
| Common Stock |
14.5K |
$408K |
$28.15 |
Apr 9, 2024 |
By Atlas Venture Associates XII, L.P. |
|
|
| Stock Option (Right to Buy) |
12.5K |
$205K |
$16.37 |
Jun 5, 2024 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.